It's difficult to prevent HPV infections that cause common warts. If you have a common wart, you can prevent the spread of the infection and formation of new warts by not picking at a wart and not biting your nails.
You may reduce the risk of contracting HPV infections that cause plantar warts by wearing shoes or sandals in public pools and locker rooms.
You can reduce your risk of developing genital warts and other HPV-related genital lesions by:
- Being in a mutually monogamous sexual relationship
- Reducing your number of sex partners
- Using a latex condom, which may prevent some but not all HPV transmission
A vaccine known as Gardasil protects against the strains of HPV that cause most genital warts. Gardasil also protects against the HPV strains most likely to cause cervical cancer. Another vaccine, called Cervarix, protects against cervical cancer but not genital warts.
The Centers for Disease Control and Prevention (CDC) recommends routine HPV vaccination for girls and boys ages 11 and 12. The vaccines are to be administered in three doses over six months. If children are not fully vaccinated at ages 11 and 12, the CDC recommends that girls and women through age 26 and boys and men through age 21 receive the vaccine. However, men may receive the HPV vaccine through age 26 if desired.
The CDC also recommends the vaccine through age 26 for men who have sex with men and for both men and women who are immune compromised if they didn't get the vaccine when younger. However, these vaccines are most effective if given before becoming sexually active.
The vaccines haven't yet been available for 10 years, but early research has already shown declining levels of genital warts. There has also been a reduction in the number of abnormalities found in cervical tissue that indicate an HPV infection.
Researchers are already working on newer vaccines that include more strains of HPV.
Sept. 16, 2014
- Markle W, et al. Sexually transmitted diseases. Primary Care Clinics: Office Practice. 2013;40:557.
- Longo DL, et al. Harrison's Online. 18th ed. New York, N.Y.: The McGraw-Hill Companies; 2012. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=4. Accessed July 8, 2014.
- Castle PE. The life cycle, natural history, and immunology of human papillomaviruses. http://www.uptodate.com/home. Accessed July 9, 2014.
- Warts. The Merck Manual for Health Care Professionals. http://www.merckmanuals.com/professional/dermatologic_disorders/viral_skin_diseases/warts.html. Accessed July 10, 2014.
- Genital HPV infection: Fact sheet. Centers for Disease Control and Prevention. http://www.cdc.gov/std/HPV/STDFact-HPV.htm. Accessed July 9, 2014.
- New guidelines for cervical cancer screening. The American College of Obstetricians and Gynecologists. https://www.acog.org/~/media/For%20Patients/pfs004.pdf?dmc=1&ts=20140719T1123120163. Accessed June 21, 2014.
- Reichman R. Epidemiology of human papillomavirus infections. http://www.uptodate.com/home. Accessed July 9, 2014.
- Goldman L, et al. Goldman's Cecil Medicine. 24th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.clinicalkey.com. Accessed July 9, 2014.
- Bolognia JL, et al., eds. Dermatology. 3rd ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.clinicalkey.com. Accessed July 9, 2014.
- Mulhem E, et al. Treatment of nongenital cutaneous warts. American Family Physician. 2011;84:288.
- HPV vaccines. Centers for Disease Control and Prevention. http://www.cdc.gov/hpv/vaccine.html. Accessed July 11, 2014.
- Muller LR, et al. Prophylactic papillomavirus vaccines. Clinics in Dermatology. 2014;32:235.
- Crowe E, et al. Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: Case-control study nested within a population based screening programme in Australia. BMJ. 2014;348:g1458.
- Luna J, et al. Long-term follow-up observation of the safety, immunogenicity, and effectiveness of Gardasil in adult women. PLoS One. 2014;8:e83431.
- Nsouli-Maktabi H, et al. Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine. MSMR. 2013;20:17.